632 related articles for article (PubMed ID: 22955364)
61. Inhibitory effects of vaginal
Takano T; Kudo H; Eguchi S; Matsumoto A; Oka K; Yamasaki Y; Takahashi M; Koshikawa T; Takemura H; Yamagishi Y; Mikamo H; Kunishima H
Front Cell Infect Microbiol; 2023; 13():1113401. PubMed ID: 37201113
[TBL] [Abstract][Full Text] [Related]
62. In vitro activity of the novel echinocandin CD101 at pH 7 and 4 against Candida spp. isolates from patients with vulvovaginal candidiasis.
Boikov DA; Locke JB; James KD; Bartizal K; Sobel JD
J Antimicrob Chemother; 2017 May; 72(5):1355-1358. PubMed ID: 28158577
[TBL] [Abstract][Full Text] [Related]
63. Correlation of Candida species and symptoms among patients with vulvovaginal candidiasis in Maringá, Paraná, Brazil.
Lopes Consolaro ME; Aline Albertoni T; Shizue Yoshida C; Mazucheli J; Peralta RM; Estivalet Svidzinski TI
Rev Iberoam Micol; 2004 Dec; 21(4):202-5. PubMed ID: 15709802
[TBL] [Abstract][Full Text] [Related]
64. Prevalence of Candida albicans, Candida dubliniensis and Candida africana in pregnant women suffering from vulvovaginal candidiasis in Argentina.
Mucci MJ; Cuestas ML; Landanburu MF; Mujica MT
Rev Iberoam Micol; 2017; 34(2):72-76. PubMed ID: 28385421
[TBL] [Abstract][Full Text] [Related]
65. Prevalence, species distribution and antifungal susceptibility of Candida albicans causing vaginal discharge among symptomatic non-pregnant women of reproductive age at a tertiary care hospital, Vietnam.
Anh DN; Hung DN; Tien TV; Dinh VN; Son VT; Luong NV; Van NT; Quynh NTN; Van Tuan N; Tuan LQ; Bac ND; Luc NK; Anh LT; Trung DM
BMC Infect Dis; 2021 Jun; 21(1):523. PubMed ID: 34082699
[TBL] [Abstract][Full Text] [Related]
66. Effect of ultra-low-dose estriol and lactobacilli vaginal tablets (Gynoflor®) on inflammatory and infectious markers of the vaginal ecosystem in postmenopausal women with breast cancer on aromatase inhibitors.
Donders G; Bellen G; Neven P; Grob P; Prasauskas V; Buchholz S; Ortmann O
Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):2023-8. PubMed ID: 26223323
[TBL] [Abstract][Full Text] [Related]
67. Activity of Novel Ultrashort Cyclic Lipopeptides against Biofilm of
Czechowicz P; Nowicka J; Neubauer D; Chodaczek G; Krzyżek P; Gościniak G
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430935
[TBL] [Abstract][Full Text] [Related]
68. Effects of probiotics on the recurrence of bacterial vaginosis: a review.
Homayouni A; Bastani P; Ziyadi S; Mohammad-Alizadeh-Charandabi S; Ghalibaf M; Mortazavian AM; Mehrabany EV
J Low Genit Tract Dis; 2014 Jan; 18(1):79-86. PubMed ID: 24299970
[TBL] [Abstract][Full Text] [Related]
69. Effect of norfloxacin therapy for acute, uncomplicated lower urinary tract infection on vaginal Candida prevalence.
Rocha RM; Zanni PC; de Souza Bonfim-Mendonça P; Gimenes F; Alczuk SS; Svidzinski TI; Consolaro ME
Int Urogynecol J; 2016 May; 27(5):773-80. PubMed ID: 26564224
[TBL] [Abstract][Full Text] [Related]
70. Antifungal susceptibilities, in vitro production of virulence factors and activities of ceragenins against Candida spp. isolated from vulvovaginal candidiasis.
Hacioglu M; Guzel CB; Savage PB; Tan ASB
Med Mycol; 2019 Apr; 57(3):291-299. PubMed ID: 29846682
[TBL] [Abstract][Full Text] [Related]
71. Difference Between the Profiles Presented by Yeasts that Colonize the Vaginal Mucosa or Cause Primary or Recurrent Candidiasis.
Moreira D; Ruiz LS; Leite-Jr DP; Auler ME; Ramos RTB; Costa VT; Lara BR; Gasparetto A; Gandra RF; Melhem MSC; Paula CR
Mycopathologia; 2021 Jun; 186(3):411-421. PubMed ID: 34120275
[TBL] [Abstract][Full Text] [Related]
72. [Inhibitory activity of vaginal Lactobacillus bacteria on yeasts causing vulvovaginal candidiasis].
Strus M; Brzychczy-Włoch M; Kucharska A; Gosiewski T; Heczko PB
Med Dosw Mikrobiol; 2005; 57(1):7-17. PubMed ID: 16130291
[TBL] [Abstract][Full Text] [Related]
73. Impact of eating probiotic yogurt on colonization by Candida species of the oral and vaginal mucosa in HIV-infected and HIV-uninfected women.
Hu H; Merenstein DJ; Wang C; Hamilton PR; Blackmon ML; Chen H; Calderone RA; Li D
Mycopathologia; 2013 Oct; 176(3-4):175-81. PubMed ID: 23925786
[TBL] [Abstract][Full Text] [Related]
74. A molecular view on the interference established between vaginal Lactobacilli and pathogenic Candida species: Challenges and opportunities for the development of new therapies.
Pedro NA; Mira NP
Microbiol Res; 2024 Apr; 281():127628. PubMed ID: 38246122
[TBL] [Abstract][Full Text] [Related]
75. Candida species isolated from the vaginal mucosa of HIV-infected women in Salvador, Bahia, Brazil.
Oliveira PM; Mascarenhas RE; Lacroix C; Ferrer SR; Oliveira RP; Cravo EA; Alves AP; Grassi MF
Braz J Infect Dis; 2011; 15(3):239-44. PubMed ID: 21670924
[TBL] [Abstract][Full Text] [Related]
76. Emergence of Vulvovaginal Candidiasis among Lebanese Pregnant Women: Prevalence, Risk Factors, and Species Distribution.
Ghaddar N; El Roz A; Ghssein G; Ibrahim JN
Infect Dis Obstet Gynecol; 2019; 2019():5016810. PubMed ID: 31467477
[TBL] [Abstract][Full Text] [Related]
77. Vaginal Candida spp. genomes from women with vulvovaginal candidiasis.
Bradford LL; Chibucos MC; Ma B; Bruno V; Ravel J
Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28582496
[TBL] [Abstract][Full Text] [Related]
78. Distribution of Candida albican genotype and Candida species is associated with the severity of vulvovagianl candidiasis.
Zeng J; Zong LL; Mao T; Huang YX; Xu ZM
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Oct; 31(10):1649-53. PubMed ID: 22027762
[TBL] [Abstract][Full Text] [Related]
79. Vaginal pH and microbiota during fluconazole maintenance treatment for recurrent vulvovaginal candidosis (RVVC).
Donders GG; Grinceviciene S; Ruban K; Bellen G
Diagn Microbiol Infect Dis; 2020 Jun; 97(2):115024. PubMed ID: 32253071
[TBL] [Abstract][Full Text] [Related]
80. Growth inhibition of Candida albicans by human vaginal epithelial cells.
Barousse MM; Steele C; Dunlap K; Espinosa T; Boikov D; Sobel JD; Fidel PL
J Infect Dis; 2001 Dec; 184(11):1489-93. PubMed ID: 11709796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
